CEMI
Income statement / Annual
Last year (2022), Chembio Diagnostics, Inc.'s total revenue was $48.34 M,
an increase of 30.91% from the previous year.
In 2022, Chembio Diagnostics, Inc.'s net income was -$23.29 M.
See Chembio Diagnostics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$48.34 M |
$36.93 M |
$30.45 M |
$34.46 M |
$33.41 M |
$24.02 M |
$17.87 M |
$24.26 M |
$27.65 M |
$29.55 M |
| Cost of Revenue |
$38.58 M
|
$34.50 M
|
$23.87 M
|
$22.39 M
|
$21.43 M
|
$12.92 M
|
$9.42 M
|
$13.77 M
|
$16.83 M
|
$17.25 M
|
| Gross Profit |
$9.76 M
|
$2.43 M
|
$6.58 M
|
$12.07 M
|
$11.98 M
|
$11.09 M
|
$8.45 M
|
$10.49 M
|
$10.81 M
|
$12.30 M
|
| Gross Profit Ratio |
0.2
|
0.07
|
0.22
|
0.35
|
0.36
|
0.46
|
0.47
|
0.43
|
0.39
|
0.42
|
| Research and Development Expenses |
$7.07 M
|
$12.49 M
|
$9.51 M
|
$8.54 M
|
$8.53 M
|
$8.56 M
|
$8.43 M
|
$6.38 M
|
$4.83 M
|
$5.83 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6.15 M
|
$5.73 M
|
$4.48 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.51 M
|
$1.78 M
|
$1.01 M
|
| Selling, General & Administrative Expenses |
$24.28 M
|
$24.84 M
|
$21.04 M
|
$16.14 M
|
$11.10 M
|
$9.02 M
|
$7.60 M
|
$7.66 M
|
$7.50 M
|
$5.49 M
|
| Other Expenses |
-$1.18 M
|
-$10.89 M
|
-$2.02 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$4.81 K
|
-$5.71 K
|
$7.50 K
|
| Operating Expenses |
$30.16 M
|
$26.44 M
|
$28.53 M
|
$24.68 M
|
$19.63 M
|
$17.58 M
|
$16.02 M
|
$14.04 M
|
$12.36 M
|
$11.30 M
|
| Cost And Expenses |
$68.74 M
|
$60.93 M
|
$52.40 M
|
$47.07 M
|
$41.05 M
|
$30.50 M
|
$25.44 M
|
$27.81 M
|
$29.20 M
|
$28.54 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$846.83 K
|
$49.50 K
|
$25.43 K
|
$25.55 K
|
$2.41 K
|
$5.84 K
|
$5.78 K
|
| Interest Expense |
$382.00 K
|
$2.91 M
|
$2.84 M
|
$846.83 M
|
$0.00
|
$2.95 K
|
$0.00
|
$836.00
|
$0.00
|
$335.00
|
| Depreciation & Amortization |
$5.79 M
|
$2.93 M
|
$2.70 M
|
$721.47 K
|
$337.65 K
|
$1.28 M
|
$1.14 M
|
$1.37 M
|
$739.30 K
|
$607.82 K
|
| EBITDA |
-$14.61 M |
-$21.07 M |
-$19.25 M |
-$861.01 M |
-$7.31 M |
-$5.18 M |
-$6.41 M |
-$2.18 M |
-$810.82 K |
$1.63 M |
| EBITDA Ratio |
-0.3
|
-0.57
|
-0.63
|
-24.98
|
-0.22
|
-0.22
|
-0.36
|
-0.09
|
-0.03
|
0.06
|
| Operating Income Ratio |
-0.42
|
-0.65
|
-0.72
|
-0.37
|
-0.23
|
-0.27
|
-0.42
|
-0.15
|
-0.06
|
0.03
|
| Total Other Income/Expenses Net |
$381.80 K
|
-$9.96 M
|
-$2.84 M
|
-$846.83 K
|
$49.50 K
|
$22.49 K
|
$25.55 K
|
-$3.24 K
|
$132.00
|
$12.94 K
|
| Income Before Tax |
-$23.26 M
|
-$33.97 M
|
-$25.98 M
|
-$14.18 M
|
-$7.93 M
|
-$6.46 M
|
-$7.55 M
|
-$3.56 M
|
-$1.55 M
|
$1.02 M
|
| Income Before Tax Ratio |
-0.48
|
-0.92
|
-0.85
|
-0.41
|
-0.24
|
-0.27
|
-0.42
|
-0.15
|
-0.06
|
0.03
|
| Income Tax Expense |
$34.41 K
|
-$62.05 K
|
-$456.79 K
|
-$500.29 K
|
-$67.52 K
|
-$88.31 K
|
$5.80 M
|
-$1.16 M
|
-$412.92 K
|
$486.95 K
|
| Net Income |
-$23.29 M
|
-$33.90 M
|
-$25.52 M
|
-$13.68 M
|
-$7.87 M
|
-$6.37 M
|
-$13.35 M
|
-$2.40 M
|
-$1.14 M
|
$530.82 K
|
| Net Income Ratio |
-0.48
|
-0.92
|
-0.84
|
-0.4
|
-0.24
|
-0.27
|
-0.75
|
-0.1
|
-0.04
|
0.02
|
| EPS |
-0.96 |
-1.4 |
-1.34 |
-0.81 |
-0.54 |
-0.52 |
-1.26 |
-0.25 |
-0.12 |
0.06 |
| EPS Diluted |
-0.96 |
-1.4 |
-1.34 |
-0.81 |
-0.54 |
-0.52 |
-1.26 |
-0.25 |
-0.12 |
0.06 |
| Weighted Average Shares Out |
$24.30 M
|
$24.30 M
|
$19.09 M
|
$16.95 M
|
$14.43 M
|
$12.30 M
|
$10.62 M
|
$9.63 M
|
$9.53 M
|
$8.99 M
|
| Weighted Average Shares Out Diluted |
$24.30 M
|
$24.30 M
|
$19.09 M
|
$16.95 M
|
$14.43 M
|
$12.30 M
|
$10.62 M
|
$9.63 M
|
$9.53 M
|
$9.52 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
